Funding for this research was provided by:
Krebsforschung Schweiz (KFS-3264-08-2013)
Federal Office of Public Health Switzerland (15.000704)
Text and Data Mining valid from 2019-01-30
Received: 10 August 2018
Accepted: 26 December 2018
First Online: 30 January 2019
Consent for publication
: Not applicable.
: This study was reviewed and approved by the ethics committees in all participating Swiss cantons (Ethics Committee Bern 194–24, Ethics Committee Northwest/Central Switzerland 2014–280, Ethics Committee Geneva 14–176, Ethics Committee Zurich 2014–0363, Ethics Committee Ticino 2839). Written informed consent was obtained from participants.
: Joakim Dillner reports previously having received funding from Merck Sharp & Dohme, a vaccine manufacturer. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.